CS241478B2 - Carrier system's particles and method of their production - Google Patents

Carrier system's particles and method of their production Download PDF

Info

Publication number
CS241478B2
CS241478B2 CS809246A CS924680A CS241478B2 CS 241478 B2 CS241478 B2 CS 241478B2 CS 809246 A CS809246 A CS 809246A CS 924680 A CS924680 A CS 924680A CS 241478 B2 CS241478 B2 CS 241478B2
Authority
CS
Czechoslovakia
Prior art keywords
particles
carrier system
biologically active
solution
suspension
Prior art date
Application number
CS809246A
Other languages
Czech (cs)
English (en)
Other versions
CS924680A2 (en
Inventor
Zoltan Riedl
Laslo Sztankov
Istvan Horvath
Original Assignee
Human Oltoanyagtermelo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo filed Critical Human Oltoanyagtermelo
Publication of CS924680A2 publication Critical patent/CS924680A2/cs
Publication of CS241478B2 publication Critical patent/CS241478B2/cs

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS809246A 1979-12-27 1980-12-23 Carrier system's particles and method of their production CS241478B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79HU299A HU184141B (en) 1979-12-27 1979-12-27 Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
CS924680A2 CS924680A2 (en) 1985-07-16
CS241478B2 true CS241478B2 (en) 1986-03-13

Family

ID=10997378

Family Applications (1)

Application Number Title Priority Date Filing Date
CS809246A CS241478B2 (en) 1979-12-27 1980-12-23 Carrier system's particles and method of their production

Country Status (21)

Country Link
US (1) US4396630A (fr)
JP (1) JPS57112334A (fr)
BE (1) BE886884A (fr)
CA (1) CA1165237A (fr)
CH (1) CH655246A5 (fr)
CS (1) CS241478B2 (fr)
DD (1) DD158738A5 (fr)
DE (1) DE3048815A1 (fr)
DK (1) DK160288C (fr)
ES (1) ES498048A0 (fr)
FR (1) FR2472386B1 (fr)
GB (1) GB2066203B (fr)
HU (1) HU184141B (fr)
IT (1) IT1150073B (fr)
NL (1) NL8007041A (fr)
PL (1) PL228755A1 (fr)
PT (1) PT72261B (fr)
RO (1) RO81371A (fr)
SE (1) SE453537B (fr)
SU (1) SU1487802A3 (fr)
YU (1) YU44413B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4806466A (en) * 1981-10-29 1989-02-21 The Regents Of The University Of California Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
DD247570A3 (de) * 1983-01-14 1987-07-15 Univ Berlin Humboldt Vesikulaeres trenn-, fuell- und traegermaterial
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
DE3584523D1 (de) * 1985-10-31 1991-11-28 Kv Pharm Co System zum freigeben von stoffen in der vagina.
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
WO1990001948A1 (fr) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Vaccin contre la grippe et nouveaux adjuvants
EP0374296B1 (fr) * 1988-12-22 1995-02-01 Dade International Inc. Lipohaptènes et utilisation de lipohaptènes liés à un support pour des tests immunologiques
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
JPH07113641B2 (ja) * 1989-11-17 1995-12-06 積水化学工業株式会社 梅毒診断試薬の製造方法
NL9000207A (fr) * 1990-01-29 1991-08-16 Duphar Int Res
JP2502234B2 (ja) * 1990-06-29 1996-05-29 カイロン コーポレイション リポソ―ム含有ワクチン組成物
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
WO1992004887A1 (fr) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Production de lymphocites t cytotoxiques
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5336507A (en) * 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AUPM500494A0 (en) * 1994-04-12 1994-05-05 Minister For Agriculture & Rural Affairs For The State Of New South Wales, The Composition for use in increasing mucosal immunity
CN1531424A (zh) * 2000-11-09 2004-09-22 ����˹��ҩ�﹫˾ Sn-38类脂络合物和应用的方法
WO2003030864A1 (fr) * 2001-05-29 2003-04-17 Neopharm, Inc. Formulation liposomale d'irinotecan
JP2005530704A (ja) * 2002-03-05 2005-10-13 トランセイブ， インク． 細胞内感染を予防及び治療するための吸入システム
AU2003296897A1 (en) * 2002-08-20 2004-05-04 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
EP3427742B1 (fr) * 2002-10-29 2020-08-12 Insmed Incorporated Liposomes contenant un aminoglycoside pour le traitement d'infections pulmonaires
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
WO2006090816A1 (fr) * 2005-02-25 2006-08-31 Mie University Procédé de fabrication de vaccin au liposome
ES2798263T3 (es) 2005-12-08 2020-12-10 Insmed Inc Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
ES2905368T3 (es) 2012-05-21 2022-04-08 Insmed Inc Sistemas para el tratamiento de infecciones pulmonares
WO2014085526A1 (fr) 2012-11-29 2014-06-05 Insmed Incorporated Formulations de vancomycine stabilisées
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
EP3773505A4 (fr) 2018-03-30 2021-12-22 Insmed Incorporated Procédés pour la fabrication continue de produits médicamenteux liposomaux
AU2019262117C1 (en) 2018-05-02 2024-12-05 Insmed Incorporated Methods for the manufacture of liposomal drug formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
GB1564500A (en) * 1975-09-29 1980-04-10 Wellcome Found Biological preparations
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell

Also Published As

Publication number Publication date
DD158738A5 (de) 1983-02-02
PT72261B (en) 1981-11-05
DK552280A (da) 1981-06-28
DE3048815A1 (de) 1981-09-10
CS924680A2 (en) 1985-07-16
NL8007041A (nl) 1981-07-16
DK160288C (da) 1991-08-05
RO81371A (fr) 1984-04-02
CA1165237A (fr) 1984-04-10
SU1487802A3 (ru) 1989-06-15
IT1150073B (it) 1986-12-10
JPS57112334A (en) 1982-07-13
JPH0314814B2 (fr) 1991-02-27
PT72261A (en) 1981-01-01
YU44413B (en) 1990-08-31
FR2472386B1 (fr) 1985-08-23
SE8009068L (sv) 1981-06-28
SE453537B (sv) 1988-02-08
ES8201316A1 (es) 1981-12-16
HU184141B (en) 1984-07-30
GB2066203B (en) 1984-01-11
CH655246A5 (de) 1986-04-15
YU329080A (en) 1984-04-30
GB2066203A (en) 1981-07-08
IT8026950A0 (it) 1980-12-24
FR2472386A1 (fr) 1981-07-03
ES498048A0 (es) 1981-12-16
BE886884A (fr) 1981-06-29
RO81371B (ro) 1983-11-02
PL228755A1 (fr) 1982-02-15
US4396630A (en) 1983-08-02
DK160288B (da) 1991-02-25

Similar Documents

Publication Publication Date Title
CS241478B2 (en) Carrier system's particles and method of their production
US5420253A (en) Method for purifying egg yolk immunoglobulins
CA1149277A (fr) Methode de dosage des complexes immuns
EP0238657B1 (fr) Agent immunotherapeutique antiviral et sa preparation
Kahn The Kahn test: a practical guide
Wilson The relationship of antibody-forming cells to rosette-forming cells
CA1337047C (fr) Compositions a base de gamma inuline
Springer et al. Erythrocyte sensitization by blood group-specific bacterial antigens
US4845042A (en) Adjuvant for immunization
US4994496A (en) Use of milk globules as carriers for drugs
CN101862456A (zh) 治疗药
US3470294A (en) Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
JPS61274739A (ja) 燐脂質小胞と、それをフゾジエニツクにする方法
EP0306971A2 (fr) Utilisation de globules de graisse de lait comme support pour médicaments et comme moyens de microflottation dans des essais immunologiques et dans la séparation des cellules et molécules
Kossovsky et al. Preservation of surface‐dependent properties of viral antigens following immobilization on particulate ceramic delivery vehicles
DE2701643A1 (de) Verfahren zur extraktion von antigenen, deren verwendung und sie enthaltende produkte
Arstila et al. Hemagglutinin of vesicular stomatitis virus
US3098011A (en) Process of producing a vaccine against distemper
Janković et al. Studies on antilymphocyte antibody in the chicken. I. Effect of rabbit antithymus and antibursa globulin on chicken embryos
CN108948192B (zh) 豚鼠免疫制备的蒜氨酸抗体
CA2171317C (fr) Methode pour purifier les immunoglobulines de jaunes d'oeufs
Mannick Inhibition by RNA of the transfer reaction following homograft sensitization
US7528240B2 (en) Method for producing human anti-thymocyte immunoglobulins
Petana et al. A modification of the indirect fluorescence test (IFT) for paracoccidioidomycosis
CN120305400A (zh) 他米巴罗汀和Toll样受体激动剂在制备疫苗佐剂中的应用